Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025
Emerging Infectious Diseases · 2026-09 · 32 (9) · 1391-1396
DOI: 10.3201/eid3209.260553 ↗Kurz gefasst
Fallbericht in der Zeitschrift Emerging Infectious Diseases, 2026-09. Verfasst von Martin Paulson und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anaplasmataceae, Anaplasmataceae Infections, Anemia, Hemolytic, Rituximab. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Paulson, M., Wennerås, C., Quarsten, H., Berg, K. K., Drivenes, A. L., Moksnes, M., & Tvedt, T. H. A. (2026). Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025. Emerging Infectious Diseases, 32(9), 1391-1396. https://doi.org/10.3201/eid3209.260553
Vancouver
Paulson M, Wennerås C, Quarsten H, Berg KK, Drivenes AL, Moksnes M, et al. Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025. Emerging Infectious Diseases. 2026;32(9):1391-1396. doi:10.3201/eid3209.260553
BibTeX
@article{Paulson2026,
author = {Paulson, Martin and Wennerås, Christine and Quarsten, Hanne and Berg, Kristine K and Drivenes, Anders L and Moksnes, Magnus and Tvedt, Tor Henrik A},
title = {Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025},
journal = {Emerging Infectious Diseases},
year = {2026},
volume = {32},
number = {9},
pages = {1391--1396},
doi = {10.3201/eid3209.260553}
}
EUVIMED